Trial · NCT07895251
Chlorhexidine Gel After Third Molar Surgery
NCT07895251, Not applicable, Completed, University of Medicine and Pharmacy at Ho Chi Minh City
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Chlorhexidine Gel After Third Molar Surgery. Trials, record NCT07895251. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07895251
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Chlorhexidine Gel After Third Molar Surgery
- NCT number
- NCT07895251
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 25 participants, actual
- Lead sponsor
- University of Medicine and Pharmacy at Ho Chi Minh City
- Conditions
- Postoperative Wound Healing
- Interventions
- Chlorhexidine 0.2% Gel
- First posted
- 2026-10-26
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Soft Tissue Healing | Postoperative days 3 and 7 after each surgery. | Soft tissue healing at each surgical site is assessed using the Early Healing Score (EHS), comprising clinical signs of re-epithelialization, hemostasis, and inflammation. The total score ranges from 0 to 10, with higher scores indicating more favorable healing. Scores are compared between chlorhexidine-treated and control sites within each participant. |
| Primary | Bacterial load | Suture sampling on postoperative day 7 after each surgery. | A 5-mm segment from the second suture knot at each surgical site is collected and placed in 2 mL of sterile saline. Following agitation and dilution, the suspension is plated on blood agar, and colonies are counted after 48 hours of incubation. Bacterial density in the original suspension is expressed as colony-forming units per milliliter (CFU/mL). Lower values indicate a lower culturable bacterial load. |
| Secondary | Postoperative Pain | Postoperative days 1, 3, and 7 after each surgery. | Participants rate pain at each surgical site using a scale ranging from 0 to 5, with higher scores indicating greater pain severity. |
| Secondary | Patient-Reported Swelling | Postoperative days 1, 3, and 7 after each surgery. | Participants rate swelling on the operated side using a scale ranging from 0 to 5, with higher scores indicating greater swelling severity. |
| Secondary | Facial Swelling | Baseline before each surgery and postoperative days 3 and 7. | Facial swelling is assessed using three extraoral distances designated AB, CD, and CE. For each distance, swelling is calculated as the postoperative measurement minus the preoperative measurement and expressed in millimeters. Greater positive changes indicate greater swelling. |
| Secondary | Trismus | Baseline before each surgery and postoperative days 3 and 7. | Maximum mouth opening is measured as the maximum interincisal distance in millimeters. Trismus is calculated as the preoperative distance minus the postoperative distance. Higher positive values indicate greater limitation of mouth opening. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07895251
GET https://conductscience.org/api/trials/v1/NCT07895251/registered